This article is part of the network’s archive of useful research information. This article is closed to new comments due to inactivity. We welcome new content which can be done by submitting an article for review or take part in discussions in an open topic or submit a blog post to take your discussions online.

Scientific title: Infectious disease aetiologies of uncomplicated febrile illness in children <5 years of age in rural Zanzibar

What did we know before this research?
Over the past decade, Zanzibar has adopted artemisinin-based combination therapy (ACT), long lasting insecticide treated nets and indoor residual spraying. As a result, Zanzibar has turned into a low transmission area with a decline of P. falciparum malaria among children with fever from approximately 30% to 1%, as well as a significant reduction of the crude child mortality. Based on these results, the Zanzibar Ministry of Health officially decided to change the target from control to elimination of malaria.

In order to reach this target, Zanzibar requires a system that provides ACT drugs only to patients who have received a formal positive diagnosis (detection of malaria parasites in the blood). Giving ACT to people who do not have malaria not only leads to the waste of expensive drugs and causes a financial burden on the health care system, but it may prevent other causes of fever from being appropriately treated. This may also increase the risk of drug resistance which could have a devastating effect on global efforts to control the disease.

What does this study add?
Zanzibar has introduced the use of rapid diagnostic tests in all public health facilities as a diagnosis mechanism that confirms the presence of malaria parasites in the blood. The tests are proposed to improve the efficiency of diagnosis, especially in remote areas where microscopy services – a laboratory-based, complex and more expensive diagnosis method – are limited.

This is a complementary study that developed from the main project, “Trusting rapid diagnostic tests in Zanzibar”. It aims to understand why children under five years old develop fever that is caused by non-malaria illnesses including pneumonia and diarrheal infections. It also assesses how rapid diagnostic tests within the Integrated Management of Childhood Illness (IMCI) determine whether patients require ACT or antibiotic.

Nurses and lab technicians took a number of laboratory tests for all children presenting with fever. Some of the samples were later transported to Sweden for PCR based analysis to detect bacteria and viruses.

The research team
Principal Investigator

Professor Anders Björkman, Karolinska Institutet

Mr. Mwinyi I. Msellem, Zanzibar Malaria Control Program, Zanzibar

Other Investigators

Dr. Kristina Elfving, University of Gothenburg
Dr. Andreas Mårtensson, Karolinska Institutet
Dr. Delér Shakely, Karolinska Institutet
Mr. Abdullah S. Ali, Zanzibar Malaria Control Program

Latest on this research
We are currently analysing data and arein the planning process for future articles and reports.

Learn more about our main study in Zanzibar, 'Trusting rapid diagnostic tests in Zanzibar'.